All In MedTech

Device Trial Radar · NCT07932080

Evaluation of the Predictive Value of Microemboli Detected by Robotic Transcranial Doppler (TCD) for the Occurrence of an Acute Ischemic Stroke (AIS) or Left Ventricular Thrombus (LVT) in ST Elevation Myocardial Infarction (STEMI) Patients With Left Ventricular Dysfunction (LVD).

Evaluation of the Predictive Value of Microemboli Detected by Robotic Transcranial Doppler for the Occurrence of an Acute Ischemic Stroke or Left Ventricular Thrombus in STEMI Patients With Left Ventricular Dysfunction

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

116

Planned (sponsor's estimate)

Start

Dec 2026

Primary completion

Dec 2027

Study completion Dec 2029

Sponsor

Lead sponsor
CHC MontlegiaAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 12, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this study is to define a correlation between the number of microembolic signals (MES) detected by the transcranial doppler and the risk of occurrence of an Acute Ischemic Stroke (AIS) at 2 years or a Left Ventricular Thrombus (LVT) at 6 weeks.

Conditions

  • STEMI
  • Left Ventricular Thrombus
  • Acute Ischemic Stroke

Interventions

  • Transcranial doppler (TCD)Device

    A TCD with MES detection will be performed the day of the inclusion. Another TCD will be performed at 6 weeks of the inclusion. Patients will then receive a follow-up call at one year, followed by a final visit two years after inclusion, blinded to the results of the TCD.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Demonstration of a correlation between the number of MES detected and the 2-year risk of AIS or the occurrence of a LVT at 6 weeks in patients with post-STEMI LVD.Time frame: To the enrollment period to 2-years of AIS or 6-weeks of a LVT

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • CHC MontLégia

    Liège, Liège, Belgium · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.